These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 16234336)
21. High-content micronucleus assay in genotoxicity profiling: initial-stage development and some applications in the investigative/lead-finding studies in drug discovery. Mondal MS; Gabriels J; McGinnis C; Magnifico M; Marsilje TH; Urban L; Collis A; Bojanic D; Biller SA; Frieauff W; Martus HJ; Suter W; Bentley P Toxicol Sci; 2010 Nov; 118(1):71-85. PubMed ID: 20631060 [TBL] [Abstract][Full Text] [Related]
22. Validated high-throughput HPLC assay for nimesulide using a short monolithic column. Tzanavaras PD; Themelis DG J Pharm Biomed Anal; 2007 Mar; 43(4):1483-7. PubMed ID: 17118614 [TBL] [Abstract][Full Text] [Related]
23. Validation of a semi-automated human hepatocyte assay for the determination and prediction of intrinsic clearance in discovery. Reddy A; Heimbach T; Freiwald S; Smith D; Winters R; Michael S; Surendran N; Cai H J Pharm Biomed Anal; 2005 Feb; 37(2):319-26. PubMed ID: 15708673 [TBL] [Abstract][Full Text] [Related]
24. Method for rapid metabolite profiling of drug candidates in fresh hepatocytes using liquid chromatography coupled with a hybrid quadrupole linear ion trap. Gao H; Materne OL; Howe DL; Brummel CL Rapid Commun Mass Spectrom; 2007; 21(22):3683-93. PubMed ID: 17937450 [TBL] [Abstract][Full Text] [Related]
25. Influence of formulation properties on chemical stability of captopril in aqueous preparations. Kristensen S; Lao YE; Brustugun J; Braenden JU Pharmazie; 2008 Dec; 63(12):872-7. PubMed ID: 19177902 [TBL] [Abstract][Full Text] [Related]
26. High-throughput screening of protein binding by equilibrium dialysis combined with liquid chromatography and mass spectrometry. Wan H; Rehngren M J Chromatogr A; 2006 Jan; 1102(1-2):125-34. PubMed ID: 16266710 [TBL] [Abstract][Full Text] [Related]
27. Stability of new potential ACE inhibitor in the aqueous solutions of different pH. Roskar R; Simoncic Z; Gartner A; Kmetec V J Pharm Biomed Anal; 2009 Feb; 49(2):295-303. PubMed ID: 19135817 [TBL] [Abstract][Full Text] [Related]
28. Application of statistical 'design of experiments' methods in drug discovery. Tye H Drug Discov Today; 2004 Jun; 9(11):485-91. PubMed ID: 15149624 [TBL] [Abstract][Full Text] [Related]
29. Upflow anaerobic sludge blanket reactor--a review. Bal AS; Dhagat NN Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675 [TBL] [Abstract][Full Text] [Related]
30. Chemical stability of the antitumor drug mitomycin C in solutions for intravesical instillation. Beijnen JH; van Gijn R; Underberg WJ J Parenter Sci Technol; 1990; 44(6):332-5. PubMed ID: 2126037 [TBL] [Abstract][Full Text] [Related]
31. Risk assessment for drug-drug interaction caused by metabolism-based inhibition of CYP3A using automated in vitro assay systems and its application in the early drug discovery process. Watanabe A; Nakamura K; Okudaira N; Okazaki O; Sudo K Drug Metab Dispos; 2007 Jul; 35(7):1232-8. PubMed ID: 17392390 [TBL] [Abstract][Full Text] [Related]
32. Applicability of bioanalysis of multiple analytes in drug discovery and development: review of select case studies including assay development considerations. Srinivas NR Biomed Chromatogr; 2006 May; 20(5):383-414. PubMed ID: 16307470 [TBL] [Abstract][Full Text] [Related]
33. Streamlined system for purifying and quantifying a diverse library of compounds and the effect of compound concentration measurements on the accurate interpretation of biological assay results. Popa-Burke IG; Issakova O; Arroway JD; Bernasconi P; Chen M; Coudurier L; Galasinski S; Jadhav AP; Janzen WP; Lagasca D; Liu D; Lewis RS; Mohney RP; Sepetov N; Sparkman DA; Hodge CN Anal Chem; 2004 Dec; 76(24):7278-87. PubMed ID: 15595870 [TBL] [Abstract][Full Text] [Related]
34. Automated approach to couple solubility with final pH and crystallinity for pharmaceutical discovery compounds. Seadeek C; Ando H; Bhattachar SN; Heimbach T; Sonnenberg JL; Blackburn AC J Pharm Biomed Anal; 2007 Apr; 43(5):1660-6. PubMed ID: 17270379 [TBL] [Abstract][Full Text] [Related]
35. Compatibility of imipenem-cilastatin sodium with commonly used intravenous solutions. Bigley FP; Forsyth RJ; Henley MW Am J Hosp Pharm; 1986 Nov; 43(11):2803-9. PubMed ID: 3467590 [TBL] [Abstract][Full Text] [Related]
36. Degradation kinetics of butylmethoxydibenzoylmethane (avobenzone) in aqueous solution. Mbah CJ Pharmazie; 2007 Oct; 62(10):747-9. PubMed ID: 18236778 [TBL] [Abstract][Full Text] [Related]
37. Stability of azacitidine in infusion fluids. Cheung YW; Vishnuvajjala BR; Morris NL; Flora KP Am J Hosp Pharm; 1984 Jun; 41(6):1156-9. PubMed ID: 6204528 [TBL] [Abstract][Full Text] [Related]
38. The development and stability assessment of extemporaneous pediatric formulations of Accupril. Freed AL; Silbering SB; Kolodsick KJ; Rossi DT; Mahjour M; Kingsmill CA Int J Pharm; 2005 Nov; 304(1-2):135-44. PubMed ID: 16191467 [TBL] [Abstract][Full Text] [Related]
39. pH-dependent effect of magnesium sulfate on the stability of penicillin G potassium solution. Das Gupta V; Stewart KR Am J Hosp Pharm; 1985 Mar; 42(3):598-602. PubMed ID: 3985024 [TBL] [Abstract][Full Text] [Related]